Year | 2004 | 2005 | 2006 | 2007 | 2008 |
---|---|---|---|---|---|
Clinic | Proportion not screened n (%; 95% CI) |
Proportion not screened n (%; 95% CI) |
Proportion not screened n (%; 95% CI) |
Proportion not screened n (%; 95% CI) |
Proportion not screened n (%; 95% CI) |
BH 1 | 29/348 (8.3; 5.4-11.2) |
32/353 (9.1; 6.1-12.1) |
16/324 (4.9; 2.6-7.3) |
18/367 (4.9; 2.7-7.1) |
11/351 (3.1; 1.3-4.9) |
BH 2 | 66/571 (11.6; 9.0-14.2) |
41/524 (7.8; 5.5-10.1) |
59/532 (11.1; 8.4-13.8) |
78/272 (28.7; 23.3-34.1) |
55/300 (18.3; 13.9-22.7) |
BH 3 | 61/602 (10.1; 7.7-12.5) |
32/618 (5.2; 3.5-7.0) |
167/645 (25.9; 22.5-29.3) |
133/742 (17.9; 15.1-20.1) |
61/738 (8.3; 6.3-10.3) |
Blk. 6 | 38/419 (9.1; 6.4-11.9) |
31/492 (6.3; 4.2-8.5) |
114/365 (31.2; 26.5-36.0) |
93/601 (15.5; 12.6-18.4) |
26/450 (5.8; 3.6-8.0) |
Blk. 8 | 20/290 (6.9; 4.0-9.8) |
13/386 (3.4; 1.6-5.2) |
64/337 (19.0; 14.8-23.2) |
60/425 (14.1; 10.8-17.4) |
14/395 (3.5; 1.7-5.3) |
Blk. 9 | 268/1097 (24.4; 21.9-26.9) |
206/872 (23.6; 20.8-26.4) |
254/755 (33.6; 30.2-37.0) |
215/777 (27.7; 24.6-30.9) |
135/1265 (10.7; 9.0-12.4) |
Ext. 2 | 29/306 (9.5; 6.2-12.8) |
21/322 (6.5; 3.8-9.2) |
55/229 (24.0; 18.5-29.5) |
56/298 (18.8; 14.4-23.2) |
23/184 (12.5; 7.7-17.3) |
Ext. 14 | 27/407 (6.6; 4.2-9.0) |
27/394 (6.9; 4.4-9.4) |
49/313 (15.7; 11.7-19.7) |
51/329 (15.5; 11.6-19.4) |
28/317 (8.8; 5.7-11.9) |
Ext. 15 | 47/378 (12.4; 9.1-15.7) |
59/406 (14.5; 11.1-17.9) |
68/216 (31.5; 25.3-37.7) |
43/204 (21.1; 15.5-26.7) |
13/358 (3.6; 1.7-5.5) |
Bontleng | 28/399 (7.0; 4.5-9.5) |
21/409 (5.1; 3.0-7.2) |
68/345 (19.7; 15.5-23.9) |
71/336 (21.1; 16.7-25.5) |
56/524 (10.7; 8.1-13.4) |
ONC | 73/735 (9.9; 7.7-12.1) |
69/715 (9.7; 7.5-11.9) |
79/738 (10.7; 8.5-12.9) |
112/730 (15.3; 12.7-17.9) |
73/728 (10.0; 7.8-12-2) |
Sebele | 24/83 (28.9; 19.2-38.7) |
08/123 (6.5; 2.1-10.9) |
25/117 (21.4; 14.0-28.8) |
14/107 (13.1; 6.7-19.5) |
07/112 (6.3; 1.8-10.8) |
BTA | 47/453 (10.4; 7.6-13.2) |
39/477 (8.2; 5.7-10.7) |
82/376 (21.8; 17.6-26.0) |
75/453 (16.6; 13.2-20.0) |
44/479 (9.2; 6.6-11.8) |
Phase 2 | 69/330 (20.9; 16.5-25.3) |
68/351 (19.4; 15.3-23.5) |
91/389 (23.4; 19.2-27.6) |
55/336 (16.4; 12.4-20.4) |
44/502 (8.8; 6.3-11.3) |